Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin

NCT00812071 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Texas Southwestern Medical Center